Table 1.
Deaths | Survivors | |||
---|---|---|---|---|
N = 20 | N = 164 | P value | ||
Age (years) | Mean | 66.6 | 66.1 | 0.55 |
Gender (%) | ||||
Male | 9 (45) | 111 (67.7) | ||
Female | 11 (55) | 53 (32.3) | ||
Interval from contact or injury to presentation at ER (days) | Mean | 2.2 | 3.4 | 0.32 |
Interval from diagnosis at ER to first operation (hours) | Mean | 4.3 | 5.8 | 0.22 |
Underlying chronic disease (%) | ||||
Hepatic dysfunction and DM | 8 (40) | 30 (18.3) | 0.037* | |
Hepatic dysfunction alone | 7 (35) | 48 (29.3) | 0.61 | |
Diabetes Mellitus alone or with others | 1 (5) | 35 (21.3) | 0.13 | |
Chronic renal insufficiency | 1 (5) | 8 (4.9) | ||
Heart disease | 2 (10) | 19 (11.6) | ||
Cancer | 1 (5) | 8 (4.9) | ||
Gout | 0 | 4 (2.4) | ||
Nil | 0 | 12 (7.3) | ||
Wound location (%) | 0.47 | |||
Upper extremity | 10 (50) | 93 (56.7) | ||
Lower extremity | 10 (50) | 61 (43.3) | ||
First operation | 0.29 | |||
Fasciotomy | 19 (95) | 162 (98.7) | ||
Amputation | 1 (5) | 2 (1.3) | ||
Final operation after first fasciotomy (%) | 19 | 162 | ||
Amputation | 2 (10.5) | 8 (4.9) | ||
Split-thickness skin graft | 0 | 80 (49.4) | ||
Flap | 0 | 6 (3.7) | ||
Debridement | 8 (42.1) | 46 (28.4) | ||
Without secondary operation | 9 (47.4) | 22 (13.6) | ||
Hospital days | Mean | 34.25 | 35.21 | 0.08 |
Hepatic dysfunction included liver cirrhosis, hepatitis B or C, hepatocellular carcinoma, and alcoholic liver disease
*Mean p < 0.05 and the difference was significant